Juhani Vartiainen

Expression of Trypsinogen-1, Trypsinogen-2, and Tumor-Associated Trypsin Inhibitor in Ovarian Cancer

Annukka Paju, Juhani Vartiainen, Caj Haglund et al. · Clinical Cancer Research · 2004 · 60 citations · Full text

Medicine, Oncology, Pathology +17

Preoperative serum concentration of hCG? as a prognostic factor in ovarian cancer

Juhani Vartiainen, Pentti Lehtovirta, Patrik Finne et al. · International Journal of Cancer · 2001 · 37 citations

Medicine, Gynecology, Oncology +16

Detection of squamous-cell carcinoma antigen-expressing tumour cells in blood by reverse transcriptase-polymerase chain reaction in cancer of the uterine cervix

Jakob Stenman, Susanna Lintula, Kristina Hotakainen et al. · International Journal of Cancer · 1997 · 35 citations · Full text

Medicine, Oncology, Pathology +17

Effects and acceptability of a new 17β-oestradiol-releasing vaginal ring in the treatment of postmenopausal complaints

Juhani Vartiainen, Torsten Wahlström, Carl-Gustaf Nilsson · Maturitas · 1993 · 34 citations

Medicine, Endocrinology, Gynecology +11

Pre‐operative serum level of tumour‐associated trypsin inhibitor and residual turnour size as prognostic indicators in Stage III epithelial ovarian cancer

Pekka Venesmaa, Ulf‐Håkan Stenman, M Forss et al. · BJOG An International Journal of Obstetrics & Gynaecology · 1998 · 31 citations

Medicine, Oncology, Surgery +17